Frank is the Chief Commercial Officer of Partex N.V. group, a 250+ people AI based asset manager with strong healthcare AI, patient data, validation, blockchain and incubation capabilities. He is currently based in Cham, Switzerland.

Before joining Partex, he served as the Global Head of Alliance Management and European Head Business Development at Everest Medicines, a company with a clinical portfolio of products predominantly focusing on China.

He used to be the VP, Head of R&D Alliance Management & Head Research Transactions, and later VP, Alliance Management, General Medicines, Emerging Markets and Consumer Health Care at Sanofi.

During his time at Sanofi, he has also been the Risk Management leader of the Strategy & Business Development group and a permanent member of the Sanofi Corporate Risk Committee. Furthermore, he has been an Advisory Board member of ASAP.

Prior to joining Sanofi, he was working in a variety of Partnering functions for Roche in China and Switzerland. Before switching to Partnering, he served in various Research positions for Roche in Switzerland and for Boehringer Mannheim in Germany. He holds a PhD in Chemistry from TU Munich (MPI Biochemistry, Martinsried, lab of Nobel laureate Robert Huber).